Oncology Today with Dr Neil Love artwork

Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar

Oncology Today with Dr Neil Love

English - October 11, 2023 15:00 - 46 minutes - 37.3 MB
Medicine Health & Fitness Science dr neil love research to practice oncology today oncology cme Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 1 of a 4-Part Series
Next Episode: Management of Metastatic Pancreatic Cancer with Dr Michael Pishvaian

Dr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York, discusses the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma.
CME information and select publications here (https://www.researchtopractice.com/OncologyTodayBispecificNHL23)

Dr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York, discusses the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma.

CME information and select publications here